Results 131 to 140 of about 2,619 (179)
Some of the next articles are maybe not open access.
Drug Delivery Letters
Topical delivery via organogels offers a promising method to deliver Lornoxicam directly to the target site with improved bioavailability, avoiding the issues associated with systemic administration.
Yeshna +6 more
semanticscholar +1 more source
Topical delivery via organogels offers a promising method to deliver Lornoxicam directly to the target site with improved bioavailability, avoiding the issues associated with systemic administration.
Yeshna +6 more
semanticscholar +1 more source
Antithrombotic potential of lornoxicam and possible mechanistic pathways.
Journal of Pharmacology and Experimental TherapeuticsLornoxicam is traditionally used as an anti-inflammatory and analgesic drug. Recent studies suggest that nonsteroidal anti-inflammatory drugs can influence platelet and coagulation pathways.
Waseem Khalid +2 more
semanticscholar +1 more source
Journal of AOAC International, 2022
OBJECTIVE This research describes the simultaneous quantitation of Paracetamol (PRM) and Lornoxicam (LRX) with five of their related substances and toxic impurities, including, 4-nitrophenol (NTP), 4-aminophenol (AMP), 4-chloroacetanilide (CAC), N ...
Amira F. El-Yazbi +3 more
semanticscholar +1 more source
OBJECTIVE This research describes the simultaneous quantitation of Paracetamol (PRM) and Lornoxicam (LRX) with five of their related substances and toxic impurities, including, 4-nitrophenol (NTP), 4-aminophenol (AMP), 4-chloroacetanilide (CAC), N ...
Amira F. El-Yazbi +3 more
semanticscholar +1 more source
Clinical Pharmacokinetics of Lornoxicam
Clinical Pharmacokinetics, 1998Lornoxican (chlorotenoxicam) is a nonsteroidal anti-inflammatory drug (NSAID) of the oxicam class. Unlike other oxicams, lornoxicam has a relatively short plasma half-life (3 to 5 hours). Lornoxicam is eliminated following biotransformation to 5'-hydroxy-lornoxicam, which does not undergo enterohepatic recirculation.
N M, Skjodt, N M, Davies
openaire +2 more sources
Journal of Pharmacy and Science, 2022
Lornoxicam physiologically based pharmacokinetic (PBPK) models were developed and validated on the basis of clinical pharmacokinetic results obtained by considering CYP2C9 genetic polymorphisms in healthy adult populations.
Seung-Hyun Jeong, J. Jang, Yong-Bok Lee
semanticscholar +1 more source
Lornoxicam physiologically based pharmacokinetic (PBPK) models were developed and validated on the basis of clinical pharmacokinetic results obtained by considering CYP2C9 genetic polymorphisms in healthy adult populations.
Seung-Hyun Jeong, J. Jang, Yong-Bok Lee
semanticscholar +1 more source
Drug Development and Industrial Pharmacy
Introduction This study aims to develop immediate release tablet formulations of lornoxicam (LRX) using hot melt extrusion (HME)-based fused deposition modeling (FDM) focusing on the adjustment of drug release by arranging infill densities and evaluating
Aysel Yılmaz +2 more
semanticscholar +1 more source
Introduction This study aims to develop immediate release tablet formulations of lornoxicam (LRX) using hot melt extrusion (HME)-based fused deposition modeling (FDM) focusing on the adjustment of drug release by arranging infill densities and evaluating
Aysel Yılmaz +2 more
semanticscholar +1 more source
Lornoxicam Solid Lipid Nanoparticle-Enriched Transdermal Gel: Development and Characterization
International Journal of Drug Delivery TechnologyTo develop antiinflammation and analgesic effects, scientists introduced lornoxicam (LRX) nanoemulsion, nanostructure lipid carriers, and solid lipid nanoparticles.
Vaibhav Dagaji Aher +3 more
semanticscholar +1 more source
European Journal of Anaesthesiology, 2010
Nonsteroidal anti-inflammatory drugs have peripheral analgesic effects. We compared the efficacy of peritonsillar infiltration versus intravenous (i.v.) lornoxicam on pain relief after tonsillectomy in adults.Sixty adult patients scheduled for tonsillectomy were randomly assigned into three groups in a double-blind placebo-controlled study.
Salah A, Ismail, Hany A, Mowafi
openaire +2 more sources
Nonsteroidal anti-inflammatory drugs have peripheral analgesic effects. We compared the efficacy of peritonsillar infiltration versus intravenous (i.v.) lornoxicam on pain relief after tonsillectomy in adults.Sixty adult patients scheduled for tonsillectomy were randomly assigned into three groups in a double-blind placebo-controlled study.
Salah A, Ismail, Hany A, Mowafi
openaire +2 more sources
Current Drug Therapy
Lornoxicam is a potent non-steroidal anti-inflammatory drug (NSAID) with strong analgesic properties; however, its short half-life necessitates frequent administration for sustained efficacy.
Hiren V. Patel +3 more
semanticscholar +1 more source
Lornoxicam is a potent non-steroidal anti-inflammatory drug (NSAID) with strong analgesic properties; however, its short half-life necessitates frequent administration for sustained efficacy.
Hiren V. Patel +3 more
semanticscholar +1 more source
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
INTRODUCTION Emulgel dosage form is an advanced form of transdermal drug de-livery. It is a combination of emulsion and gel in a definite ratio. Emulsions are incorporated into the gel with proper mixing. The emulsion present in emulgel can be either oil/
Vibha Kumari, Meenakshi Bajpai
semanticscholar +1 more source
INTRODUCTION Emulgel dosage form is an advanced form of transdermal drug de-livery. It is a combination of emulsion and gel in a definite ratio. Emulsions are incorporated into the gel with proper mixing. The emulsion present in emulgel can be either oil/
Vibha Kumari, Meenakshi Bajpai
semanticscholar +1 more source